Skip to main content
Clinical Trials/NCT05777941
NCT05777941CompletedNot Applicable

Strength Training With Eccentric Arm-cranking in Para-athletes

Swiss Paraplegic Research, Nottwil2 sites in 1 country12 target enrollmentStarted: December 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
12
Locations
2
Primary Endpoint
Upper body Performance

Study Overview

Brief Summary

The new training device, the eccentric arm-crank, will be examined for its training effects in athletes with a spinal cord injury (SCI) by this project. That the training device can be used in patients with paraplegia in the future, the so-called "testing of the applicability of this concept" will be carried out during this study. Fourteen volunteer, healthy athletes with SCI are first tested for their upper body performance, followed by a training phase over 20 trainings and at the end the performance data is collected again. The training intensity and duration is continuously increased during the training phase.

Detailed Description

At the beginning, the study design includes a familiarisation appointment with performance tests and training on the eccentric arm-crank device (KREHA). At least one week later, the first test sequence including a maximum strength test (bench press) and a test to determine the anaerobic performance (Wingate test) is conducted. The second test sequence takes place one to three days later. This includes a handgrip strength test, an aerobic endurance test (ramp test on the arm crank ergometer with ergospirometry) and a further familiarisation training on the KREHA. The training phase starts within two weeks after the pre-tests have been completed. There are two to a maximum of three trainings per week. These take 30 to 45 minutes and take place on the KREHA device under the supervision of the study staff. The training phase lasts a maximum of twelve weeks (20 training sessions). The first test sequence is repeated five to eight days after the last workout. The second test sequence takes place at the same time interval as in the pre-tests.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • male or female with traumatic or disease-related SCI
  • age between 18 and 50 years
  • experience in strength training
  • Squad status or at least 4h per week training
  • Biceps/triceps function
  • healthy(study physician)
  • adequately informed and confirmed per signature

Exclusion Criteria

  • findings during anamnesis of study physician
  • pregnancy

Arms & Interventions

Eccentric Training

Experimental

This Group will train on the KREHA for 20 Trainings

Intervention: eccentric arm-cranking training (Other)

Outcomes

Primary Outcomes

Upper body Performance

Time Frame: through study completion, an average of 20 weeks

Peak Power - maximal reached power, generated during the 30sec Wingate arm-crank test

Secondary Outcomes

  • Endurance Oxygen consumption(through study completion, an average of 20 weeks)
  • Upper body Fatigue Slope(through study completion, an average of 20 weeks)
  • Lower Arm Circumference(through study completion, an average of 20 weeks)
  • Maximal Workload(through study completion, an average of 20 weeks)
  • Upper body Power - Time to Peak(through study completion, an average of 20 weeks)
  • 1RM bench press(through study completion, an average of 20 weeks)
  • Grip Strength(through study completion, an average of 20 weeks)
  • Upper Arm Circumference(through study completion, an average of 20 weeks)
  • Upper body Mean Power(through study completion, an average of 20 weeks)
  • Upper body Fatigue Index(through study completion, an average of 20 weeks)

Investigators

Sponsor
Swiss Paraplegic Research, Nottwil
Sponsor Class
Network
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Strength Training With Eccentric... | Clinical Trial